register

Digital & Innovation

Healthtech company and CSIRO bring innovation to spinal surgery

Health Industry Hub | April 7, 2021 |

Digital & Innovation: Recently ASX-listed healthtech company and Australia’s national science agency CSIRO have announced their successful collaboration of developing an automated segmentation of a spinal vertebra from CT scans.

This innovation allows surgeons and radiologists to not just visualise the spine in 3D using Singular’s software, but also to manipulate individual vertebrae, better plan surgeries and even allow customised surgical implants and guides.

Singular Health Group’s automated segmentation has an accuracy rate above 95%. Once edited by radiologists and surgeons this increases to 100%.

Executive Director of Innovation at Singular Health, Dr Guan Tay, said he believes the use of AI will disrupt the medical imagery industry.

MedTech News - Market access and funding key barriers to MedTech innovation, says President of Stryker Asia-Pacific

“The use of artificial intelligence in medical imaging, and more specifically radiology, has the ability to profoundly change the workflow for radiologists.

“With around 45,000 Australians undergoing spinal surgery every year, the rapid segmentation will save thousands of hours for radiologists and surgeons who will only have to make small mark-ups and/or validate the segmentation as opposed to manual segmentation slice-by-slice,” said Dr Tay.

The analysis and segmentation only takes about two minutes using Singular’s MedVR & 3DicomViewer software. This makes the process semi-automated as surgeons and radiologists can edit the output in order to ensure compliance with the imaging.

To put this into perspective, the manual segmentation process by medical practitioners usually takes hours.

Rather tediously, the manual process involves identifying and marking verterbrae on every single CT slice, of which there can be hundreds. Unsurprisingly, this task can be mentally fatiguing.

Dr Dadong Wang, the Quantitative Imaging Research Team Leader at CSIRO’s Data 61, praised the user-friendliness of the new innovation.

“CSIRO has been able to apply data science and Artificial Intelligence to enable users to better visualise the spine and individual vertebrae. This semi-automated segmentation and labelling of the spinal vertebrae is both time saving and can be represented in 3D models, which can also be viewed in virtual reality, providing higher interactivity,” commented Dr Wang.

The project received funding and support from the CSIRO Kick-Start initiative, a program that gives Australian start-ups and small businesses access to CSIRO’s research and development expertise and capabilities.


ESG

Landmark National Health and Climate Strategy to roll out 'green procurement guidelines' for medicines and surgical supplies

Landmark National Health and Climate Strategy to roll out ‘green procurement guidelines’ for medicines and surgical supplies

Health Industry Hub | December 5, 2023 |

ESG: At the 28th United Nations Climate Conference (COP28) in Dubai, Ged Kearney MP, Assistant Minister for Health and Aged […]

More


News & Trends - Pharmaceuticals

A strategic alignment for HTA Review: Professor Skerritt appointed to Medicines Australia Board

A strategic alignment for HTA Review: Professor Skerritt appointed to Medicines Australia Board

Health Industry Hub | December 5, 2023 |

Pharma News: Professor John Skerritt has been appointed as an Independent Selected Director on the Medicines Australia Board effective 4 […]

More


News & Trends - MedTech & Diagnostics

Breath of change: Cystic Fibrosis Australia forges pioneering partnership with local medtech

Breath of change: Cystic Fibrosis Australia forges pioneering partnership with local medtech

Health Industry Hub | December 5, 2023 |

MedTech & Diagnostics News: In a move aimed at enhancing cystic fibrosis (CF) care and support, Australian-based medical device company, […]

More


News & Trends - Pharmaceuticals

Does the evidence support safety concerns following CAR-T cell therapies?

Does the evidence support safety concerns following CAR-T cell therapies?

Health Industry Hub | December 5, 2023 |

Pharma News: The U.S. Food and Drug Administration (FDA) has launched an investigation into a concerning risk associated with CAR-T […]

More


This content is copyright protected. Please subscribe to gain access.